Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.

The Lancet. Oncology - 1 Mar 2021

Gibson Joanna A, Finberg Karin E, Nalbantoglu ILKe, Cecchini Michael, Ganzak Amanda, Walther Zenta, Sklar Jeffrey L, Eder Joseph P, Goldberg Sarah B

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Diagnosis, Differential
Share to Gallbladder Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mesothelioma

Share to Molecular Targeted Therapy

Share to Peritoneal Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 33662283
DOI: 10.1016/S1470-2045(20)30683-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.PMID 33662283Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

Special report: multiple molecular testing of cancers to identify targeted therapies.Semantic proximity Read ↗

Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes.Semantic proximity Read ↗

Precision Oncology: Who, How, What, When, and When Not?Semantic proximity Read ↗

Advances in Personalized OncologySemantic proximity Read ↗

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemSemantic proximity Read ↗

Molecular profiling for precision cancer therapiesSemantic proximity Read ↗

[Molecular diagnostics in oncology].Semantic proximity Read ↗

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsSemantic proximity Read ↗

Precision Oncology Decision Support: Current Approaches and Strategies for the Future.Semantic proximity Read ↗

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.Semantic proximity Read ↗

Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer TherapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.